Vincerx Pharma
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$40,157,000 over the previous period. Total operating expenses were $42,609,000.
Profit Margin
| 2019 | 0 | -45K | |
|---|---|---|---|
| 2020 | 0 | -10.73M | |
| 2021 | 0 | -15.60M | |
| 2022 | 0 | -57.16M | |
| 2023 | 0 | -40.15M |
VINCU Income Statement (2019 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Revenue | |||||
Revenue | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 915K | 939K | 340K | 172.99K | 0 |
Gross profit | -915K | -939K | -340K | -172.99K | 0 |
Operating exp. | |||||
Research and development | 28.97M | 52.15M | 40.08M | 7.11M | 0 |
Selling and marketing | 0 | 0 | 0 | 0 | 44.94K |
Total operating expenses | 42.60M | 71.10M | 62.65M | 10.71M | 45K |
Operating income | -42.60M | -73.57M | -62.65M | -10.71M | -45K |
Other income (expenses), net | 2.45M | 8.20M | 23.35M | -5.90M | 0 |
Income before tax | -40.15M | -65.36M | -39.30M | -10.72M | -45K |
Income tax expense | 0 | -8.20M | -23.69M | 8K | -54 |
Net income | -40.15M | -57.16M | -15.60M | -10.73M | -45K |
Earnings per share | |||||
Basic EPS | -1.89 | -2.72 | -0.91 | -0.77 | -0.00 |
Diluted EPS | -1.89 | -2.72 | -0.91 | -0.77 | -0.00 |
| Data source | Data source | Data source | Data source |